Southland Equity Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$354K Buy
3,859
+14
+0.4% +$1.23K 0.06% 222
2026
Q1
$328K Sell
3,845
-60
-2% -$5.35K 0.06% 201
2025
Q4
$309K Buy
3,905
+11
+0.3% +$862 0.06% 200
2025
Q3
$311K Buy
3,894
+9
+0.2% +$768 0.06% 186
2025
Q2
$353K Sell
3,885
-5
-0.1% -$456 0.08% 163
2025
Q1
$364K Buy
3,890
+9
+0.2% +$806 0.08% 155
2024
Q4
$353K Buy
3,881
+813
+26% +$77.6K 0.08% 152
2024
Q3
$318K Buy
3,068
+422
+16% +$43K 0.08% 163
2024
Q2
$257K Buy
2,646
+8
+0.3% +$738 0.07% 178
2024
Q1
$238K Hold
2,638
0.07% 189
2023
Q4
$210K Buy
+2,638
New +$198K 0.07% 188

Other funds holding CL

Southland Equity Partners's CL Position: Q2 2026 in Review

Southland Equity Partners increased its Colgate-Palmolive (CL) stake by 0.36% in Q2 2026, buying an estimated $1.23K and bringing the position to 3,859 shares worth $354K. The position accounts for 0.06% of the portfolio, ranked #222.

Southland Equity Partners first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $364K in Q1 2025. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Southland Equity Partners held 3,859 shares of Colgate-Palmolive worth $354K as of Q2 2026.
  • Southland Equity Partners bought 14 Colgate-Palmolive shares in Q2 2026, an estimated $1.23K.
  • Colgate-Palmolive made up 0.06% of Southland Equity Partners's portfolio in Q2 2026, its #222 holding.
  • Southland Equity Partners first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • Southland Equity Partners's Colgate-Palmolive position peaked at $364K in Q1 2025.
  • 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Southland Equity Partners's 13F filing for Q2 2026, filed 13 Jul 2026.